Kirtikumar Modi
Medwin Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kirtikumar Modi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:29 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00814372 · Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminGilead Sciences · terminated · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:29 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis.Diabetes Metab Syndr · 201136 citationsRCR 1.1
- Closed-loop digital meditation for neurocognitive and behavioral development in adolescents with childhood neglect.Transl Psychiatry · 202031 citationsRCR 2.2
- Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.J Assoc Physicians India · 200815 citationsRCR 0.5
- Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.Arch Dermatol Res · 202010 citationsRCR 1.3